(4-Methylamino-benzoylamino)-acetic acid | 68352-82-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-Methylamino-benzoylamino)-acetic acid
• 英文别名: 2-[[4-(Methylamino)benzoyl]amino]acetic acid
• CAS: 68352-82-9
• 化学式: C₁₀H₁₂N₂O₃
• 分子量: 208.217
• InChiKey: NBPLUJAQHHHGBQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  78.4
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• [EN] METHOD FOR PURIFICATION OF ANTIBODIES, ANTIBODY FRAGMENTS OR ENGINEERED VARIANTS THEREOF USING SPECIFIC ANTHRAQUINONE DYE-LIGAND STRUCTURES<br/>[FR] MÉTHODE DE PURIFICATION D'ANTICORPS, DE FRAGMENTS OU DE VARIANTS GÉNÉTIQUEMENT MODIFIÉS DESDITS ANTICORPS, AU MOYEN DE STRUCTURES DE LIGANDS COLORANTS D'ANTHRAQUINONE SPÉCIFIQUES
  申请人：BASF SE

  公开号：WO2015117984A1

  公开（公告）日：2015-08-13

  The present invention relates to novel adsorbents applicable a process for the separation or purification of antibodies, antibody fragments or engineered variants thereof, which comprise anthraquinone dye ligands; corresponding purification processes; and corresponding analytical or preparative separation kits.

  本发明涉及一种新型吸附剂，适用于分离或纯化抗体、抗体片段或工程变体的过程，其中包括蒽醌染料配体；相应的纯化过程；以及相应的分析或制备分离试剂盒。
• Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures
  申请人：BASF SE

  公开号：EP2918641A1

  公开（公告）日：2015-09-16

  The present invention relates to novel adsorbets applicable a process for the separation or purification of antibodies, antibody fragments or engineered variants thereof, which comprise anthraquinone dye ligands; corresponding purification processes; and corresponding analytical or preparative separation kits.

  本发明涉及新型吸附剂，适用于抗体、抗体片段或其工程变体的分离或纯化过程，其中包括蒽醌染料配体；相应的纯化过程；以及相应的分析或制备分离试剂盒。
• METHOD FOR PURIFICATION OF ANTIBODIES, ANTIBODY FRAGMENTS OR ENGINEERED VARIANTS THEREOF USING SPECIFIC ANTHRAQUINONE DYE-LIGAND STRUCTURES
  申请人：BASF SE

  公开号：EP3102637B1

  公开（公告）日：2018-04-11
• SYSTEMS AND METHODS FOR MANUFACTURING BIOLOGICALLY-PRODUCED PRODUCTS
  申请人：Massachusetts Institute of Technology

  公开号：US20200224144A1

  公开（公告）日：2020-07-16

  Aspects of the present disclosure relate to systems and methods for manufacturing biologically-produced pharmaceutical products. Some of the systems described herein comprise an upstream component comprising a bioreactor and at least one filter (e.g., a filter probe) integrated with a downstream component comprising a purification module comprising at least a first partitioning unit and a second partitioning unit. In some embodiments, these integrated biomanufacturing systems may be operated under continuous or conditions and may be capable of efficiently producing pure, high-quality pharmaceutical products.
• SYSTEMS AND METHODS FOR USING BEHAVIOR DATA OF IMPURITIES AND TARGET PROTEINS TO DESIGN DOWNSTREAM PROCESSES
  申请人：Massachusetts Institute of Technology

  公开号：US20200251186A1

  公开（公告）日：2020-08-06

  Systems and methods for generating and evaluating candidate sequences of partitioning steps to partition at least one biologically produced product from at least one impurity. In some embodiments, a plurality of candidate sequences of partitioning steps may be generated, wherein at least one candidate sequence of the plurality of candidate sequences comprises a plurality of partitioning steps in a specified order. The plurality of candidate sequences may be evaluated. For instance, a data set associated with the at least one partitioning step may be accessed, the data set comprising: first data indicative of a behavior of the at least one biologically produced product with respect to the at least one partitioning step; and second data indicative of a behavior of the at least one impurity with respect to the at least one partitioning step. The at least one candidate sequence may be scored based at least in part on the data set.